6.065
price up icon12.29%   0.735
 
loading
前日終値:
$5.33
開ける:
$6
24時間の取引高:
41,710
Relative Volume:
0.20
時価総額:
$113.04M
収益:
$264.74M
当期純損益:
$-49.71M
株価収益率:
-10.64
EPS:
-0.57
ネットキャッシュフロー:
$-43.55M
1週間 パフォーマンス:
-37.72%
1か月 パフォーマンス:
-45.09%
6か月 パフォーマンス:
+60.89%
1年 パフォーマンス:
-26.68%
1日の値動き範囲:
Value
$5.66
$6.47
1週間の範囲:
Value
$5.15
$9.99
52週間の値動き範囲:
Value
$0.3901
$87.50

Calamp Corp Stock (CAMP) Company Profile

Name
名前
Calamp Corp
Name
セクター
Healthcare (1195)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
@calamp
Name
次回の収益日
2024-07-25
Name
最新のSEC提出書
Name
CAMP's Discussions on Twitter

CAMP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CAMP 6.065 113.04M 264.74M -49.71M -43.55M -0.57
VRTX 450.63 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.05 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.59 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.57 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.97 24.89B 3.30B -501.07M 1.03B 11.54

Calamp Corp Stock (CAMP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-08-16 アップグレード Craig Hallum Hold → Buy
2021-12-22 ダウングレード Craig Hallum Buy → Hold
2021-09-24 繰り返されました Craig Hallum Buy
2021-06-25 繰り返されました Craig Hallum Buy
2020-12-18 ダウングレード JP Morgan Neutral → Underweight
2020-04-17 アップグレード Jefferies Hold → Buy
2020-03-05 繰り返されました Craig Hallum Buy
2019-12-20 繰り返されました Craig Hallum Buy
2019-12-20 ダウングレード First Analysis Sec Outperform → Neutral
2019-06-28 アップグレード Northland Capital Market Perform → Outperform
2019-05-29 ダウングレード Goldman Neutral → Sell
2019-05-01 繰り返されました Craig Hallum Buy
2019-03-25 ダウングレード JP Morgan Overweight → Neutral
2019-01-25 アップグレード JP Morgan Neutral → Overweight
2018-12-21 アップグレード Craig Hallum Hold → Buy
2018-12-14 繰り返されました B. Riley FBR Buy
2018-12-11 ダウングレード First Analysis Sec Strong Buy → Outperform
2018-12-11 ダウングレード Northland Capital Outperform → Market Perform
2018-11-27 開始されました Goldman Neutral
2018-10-15 開始されました Jefferies Hold
2018-09-28 繰り返されました Craig Hallum Hold
2018-04-27 繰り返されました Craig Hallum Hold
2018-03-08 ダウングレード Craig Hallum Buy → Hold
2018-02-16 アップグレード First Analysis Sec Equal-Weight → Overweight
すべてを表示

Calamp Corp (CAMP) 最新ニュース

pulisher
Nov 20, 2024

CalAmp Files Bankruptcy to Complete Debt Restructuring - MSN

Nov 20, 2024
pulisher
Nov 08, 2024

William Blair Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform Recommendation - MSN

Nov 08, 2024
pulisher
Nov 08, 2024

October IPOs in Biotech, Cleantech, Transportation, Retail and Homebuilder Sectors - Investorideas.com newswire

Nov 08, 2024
pulisher
Nov 06, 2024

Camp4 Therapeutics initiated with an Overweight at Piper Sandler - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

JP Morgan Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight Recommendation - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

JPMorgan sees "breakthrough potential" in CAMP4 stock, bets big on RNA tech - Investing.com Australia

Nov 06, 2024
pulisher
Nov 05, 2024

CAMP4 Analyst Highlights Rare Disease Platform Potential - Benzinga

Nov 05, 2024
pulisher
Nov 05, 2024

Camp4 gains after earning bullish views on Street - MSN

Nov 05, 2024
pulisher
Nov 05, 2024

Camp4 stock gains after earning bullish views (CAMP:NASDAQ) - Seeking Alpha

Nov 05, 2024
pulisher
Nov 05, 2024

William Blair upbeat on CAMP4 shares with Outperform rating - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

William Blair upbeat on CAMP4 shares with Outperform rating By Investing.com - Investing.com Canada

Nov 05, 2024
pulisher
Nov 05, 2024

Leerink sets stock target for CAMP4, cites broad UCD treatment potential - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Piper Sandler optimistic on CAMP4 stock, cites potential in pioneering RNA technology - Investing.com

Nov 05, 2024
pulisher
Oct 25, 2024

Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline

Oct 25, 2024
pulisher
Oct 25, 2024

Internet of Things (IoT) in Construction Market Worth Over $61.7 Billion by 2030Industry Analysis and Forecast with Profiles of 37 Major Companies Including Autodesk, Calamp Corp, Caterpillar, Dronedeploy - GlobeNewswire

Oct 25, 2024
pulisher
Oct 25, 2024

CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN

Oct 25, 2024
pulisher
Oct 20, 2024

Warren Buffett and Biotech IPOs Highlight Recent Insider Buying - 24/7 Wall St.

Oct 20, 2024
pulisher
Oct 18, 2024

Camp4 Therapeutics sees $8.4 million stock purchase by Northpond Ventures - Investing.com India

Oct 18, 2024
pulisher
Oct 18, 2024

Camp4 Therapeutics sees $7.99m stock purchase by investors By Investing.com - Investing.com India

Oct 18, 2024
pulisher
Oct 18, 2024

Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com India

Oct 18, 2024
pulisher
Oct 18, 2024

CAMP4 Rings the Opening Bell - Nasdaq

Oct 18, 2024
pulisher
Oct 16, 2024

Insider Trading Activity Tuesday: Top Buys and Sells in US Stocks Revealed - Investing.com

Oct 16, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics sees $9.99 million stock purchase by Polaris - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics sees $9.99 million stock purchase by 5AM Ventures - Investing.com Australia

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics director Nashat Amir buys $9.99m in stock - Investing.com India

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics director Nashat Amir buys $9.99m in stock By Investing.com - Investing.com Australia

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics director Andrew Schwab buys $9.99m in stock - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Camp4 Therapeutics director Andrew Schwab buys $9.99m in stock By Investing.com - Investing.com South Africa

Oct 15, 2024
pulisher
Oct 15, 2024

Upstream Bio and Camp4 and Ceribell Transactions - William Blair

Oct 15, 2024
pulisher
Oct 14, 2024

CAMP4 Therapeutics’ $75 Million IPO - Global Legal Chronicle

Oct 14, 2024
pulisher
Oct 14, 2024

Opening Day: Another trio of biotech IPOs make Friday debut - Yahoo Finance

Oct 14, 2024
pulisher
Oct 13, 2024

Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN

Oct 13, 2024
pulisher
Oct 12, 2024

CAMP4 stock edges up 2% following $75M IPO - MSN

Oct 12, 2024
pulisher
Oct 11, 2024

Upstream catches aftermarket updraft, as Camp4 IPO gets muted reception - BioCentury

Oct 11, 2024
pulisher
Oct 11, 2024

Finance Watch: 2024 Has Now Beaten 2023’s Total Of 21 IPOs - Scrip

Oct 11, 2024
pulisher
Oct 11, 2024

Upstream Bio Shares Rise 26% to Lead Burst of Life Sciences IPOs - MSN

Oct 11, 2024
pulisher
Oct 11, 2024

6 Firms Guide IPO Trio From Biotech, Medical Device Cos. - Law360

Oct 11, 2024

Calamp Corp (CAMP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Calamp Corp (CAMP) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
AH Equity Partners Bio I, L.L.
10% Owner
Oct 15 '24
Buy
11.00
727,272
7,999,992
1,579,885
Enavate Sciences GP, LLC
10% Owner
Oct 15 '24
Buy
11.00
1,363,636
14,999,996
3,785,802
Polaris Management Co. VII, L.
10% Owner
Oct 15 '24
Buy
11.00
909,090
9,999,990
909,090
5AM Partners VI, LLC
10% Owner
Oct 15 '24
Buy
11.00
909,090
9,999,990
2,625,145
Nashat Amir
Director
Oct 15 '24
Buy
11.00
909,090
9,999,990
909,090
Schwab Andrew J.
Director
Oct 15 '24
Buy
11.00
909,090
9,999,990
2,625,145
Cohenour Jason
Director
Jun 05 '24
Sale
0.83
8,640
7,176
0
Cohenour Jason
Director
Mar 05 '24
Option Exercise
0.00
7,824
0
10,962
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):